Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Trial of Perifosine in Patients Currently Being Treated on Perifosine Trials in Solid Tumors or Multiple Myeloma

NCT00847366 is registered in ClinicalTrials.gov with AEterna Zentaris as lead sponsor.

NCT NCT00847366
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00847366 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Trial of Perifosine in Patients Currently Being Treated on Perifosine Trials in Solid Tumors or Multiple Myeloma
Lead sponsor
AEterna Zentaris
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2008
Completion date
December 31, 2012
Enrollment
10 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic breast cancer, non small cell lung cancer, sarcomas, solid tumors